Predict your next investment

Corporation
HEALTHCARE | Biotechnology
curagen.com

See what CB Insights has to offer

Founded Year

1991

Stage

Acq - P2P | Acquired

Total Raised

$39.29M

Valuation

$0000 

About CuraGen

CuraGen is a Healthcare/Biotechnology company based in Branford, Connecticut. CuraGen's investors include Cooper Hill Partners and Soros Fund Management.

CuraGen Headquarter Location

322 East Main Street

Branford, Connecticut, 06405,

United States

203-481-1104

Latest CuraGen News

Clovis Oncology adds former Pfizer VP to board

Jul 13, 2021

BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CuraGen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CuraGen is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CuraGen Patents

CuraGen has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/26/2014

5/14/2019

Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/26/2014

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/14/2019

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.